tyrate, a relatively poor metabolized short-chain fatty acid (SCFA), induces HCO 3 secretion via a Cl-independent, DIDS-insensitive, carrier-mediated process as well as inhibiting both Cl-dependent and cAMP-induced HCO 3 secretion. The mechanism(s) responsible for these processes have not been well characterized. HCO3 secretion was measured in isolated colonic mucosa mounted in Lucite chambers using pH stat technique and during microperfusion of isolated colonic crypts.
little is known about the SCFA-dependent HCO 3 secretion, recent studies indicate that SCFA induce HCO 3 secretion via a Cl-independent, DIDS-insensitive process that probably involves an apical membrane SCFA/HCO 3 exchange (42) . Because SCFA could stimulate HCO 3 secretion as a result of their membrane transport and/or metabolism, these initial studies were performed with a poorly metabolized SCFA, isobutyrate (42) . Additional studies of HCO 3 secretion with butyrate would be required to establish the relative contribution of metabolism and transport to overall SCFA-dependent HCO 3 secretion.
At least three different modes of HCO 3 secretion in the rat distal colon have been identified as 1) Cl-dependent, 2) cAMPinduced, and 3) SCFA-dependent, which have been characterized by their distribution to surface and crypt cells, dependence on lumen Cl, and response to 100 M DIDS, an inhibitor of Cl/anion exchange, and to 100 M 5-nitro-3-(3-phenylpropyl-amino)benzoic acid (NPPB), a nonspecific inhibitor of anion channels (42) . Cl-dependent HCO 3 secretion is a DIDS-sensitive and NPPB-insensitive process located in surface epithelial but not in crypt epithelial cells. In contrast, cAMP-induced HCO 3 secretion is both Cl-independent and DIDS-insensitive but is NPPB-sensitive, located in crypt and possibly in surface epithelial cells (13) . The exact site for SCFA-dependent HCO 3 secretion is not known, but because SCFA absorption is presumably a transport process located in surface cells, SCFA-dependent HCO 3 secretion is likely present in surface cells. Furthermore, SCFA-dependent HCO 3 secretion has recently been established as Cl insensitive and both DIDS and NPPB insensitive (42) . SCFA have also been shown to inhibit both cAMP-induced and Cl-dependent HCO 3 secretion, but little is known about the mechanism of this downregulation.
These present studies were designed to explore in detail the mechanism of butyrate-dependent HCO 3 secretion with emphasis on the role of both SCFA transport and metabolism in the genesis of colonic HCO 3 secretion; the cellular site(s) of SCFA-dependent HCO 3 secretion; and the interrelationship between SCFA and both Cl-dependent and cAMP-induced HCO 3 secretion.
MATERIALS AND METHODS
Male Sprague-Dawley rats weighing ϳ200 -250 g were used in all experiments. Rats were killed by exsanguination. The experimental protocols described in this communication were approved by the Yale University Institutional Animal Care and Use Committee.
pH Stat Technique
HCO3 secretion was determined by pH stat methods recently described in detail (42) . In brief, colonic mucosa stripped of serosal and muscular layers were mounted in Lucite chambers under voltage clamp conditions. The standard serosal solution contained (in mM) 140 Na, 5.2 K, 119.8 Cl, 25 HCO 3, 2.4 HPO4, 0.4 H2PO4, 1.2 Ca, 1.2 Mg. Colonic tissues were always exposed to a buffered solution on the serosal side, whereas the lumen side was always a HCO 3-free, low-buffered solution (0.1 mM HEPES-Tris buffer, pH 7.4). Composition of the several solutions used in these experiments is presented in Table 1 and depended on the specific experiment being performed. HCO 3-containing solutions were gassed with 95% O2-5% CO2, and the HCO3-free solutions were gassed with 100% O2. In isobutyrate kinetic studies (0 -25 mM) isosmolarity was maintained by varying concentration of isethionate. All experimental solutions were calibrated by using a known quantity of 0.025 N H 2SO4 added against known concentration of HCO3 to obtain a linear curve. The determined quantity of HCO3 was always within the linear range of this curve for all lumen solutions. The pH stat technique involved a constant maintenance of pH by addition of 0.025 N H 2SO4. HCO3 secretion was defined as the amount of acid required to maintain a constant (or stat) pH over a period of time and is expressed as eq ⅐ h Ϫ1 ⅐ cm 2 . HCO3 secretion was constant for at least 80 min. Because HCO3 secretion was defined as the amount of acid required to maintain the pH at 7.4, prior studies evaluated the possibility that parallel proton secretion, i.e., secondary to Na ϩ /H ϩ exchange (NHE) and H ϩ -K ϩ -ATPase, was present, which had resulted in an underestimation of HCO3 secretion (42) . In those studies, removal of lumen Na, addition of lumen 1 mM amiloride, or addition of lumen 1 mM amiloride plus removal of lumen Na did not increase HCO 3 secretion. Because these studies suggested the absence of a functional NHE, unidirectional 22 Na fluxes were performed to determine net Na absorption (JnetNa). Because these experiments demonstrated an absence of JnetNa, it was concluded that the serosal-to-lumen HCO 3 gradient was responsible for the absence of JnetNa. In additional studies, the addition of 1 mM orthovanadate, an inhibitor of ATPases, resulted in a 7% increase in HCO 3 secretion. As a result, use of the pH stat method to determine HCO3 secretion does not substantially underestimate actual rate of HCO3 secretion secondary to unrecognized proton secretion (42) .
Crypt Microperfusion
Individual crypts were obtained from the distal colon by hand dissection. Net fluid movement was determined by using microperfusion technology with 3 H-labeled inulin, as previously described (13) . Results are expressed as nl ⅐ mm Ϫ1 ⅐ min Ϫ1 . HCO3 secretion was determined from net fluid movement and HCO3 concentration ([HCO3]) in both perfusate and effluent.
[HCO3] was measured by thermogenic determination using a picapnotherm previously standardized in this laboratory (13) . Net HCO3 movement is expressed as picamoles per millimeter per minute. Each data point represents the average of three 5-min collections of effluent. At least five crypts were studied in each experiment. At the end of the experiment, the viability of the crypt was assessed with trypan blue, and experiments in which cells failed to exclude dye were discarded. Positive values represent net absorption, and negative ones, net secretion. Solutions used with microperfusion were equilibrated with 5% CO2 and adjusted to an osmolality of 300 -310 osmol/kg. In the nominally CO2/HCO3-free solutions, 32 mM HEPES replaced 22 mM NaHCO3 and the solution was air equilibrated. The pH of all solution was 7.4 at 37°C.
Vesicle Preparation and Uptake Studies
Apical membrane vesicles (AMV) were prepared from both surface and crypt cells of normal rat distal colon, as previously described (28) . Surface cell AMV was prepared by the method of Stieger et al. (39) . Crypt cell AMV was isolated by the method of Lomax et al. (21) . Initial rate of 14 C-butyrate (Amersham, Arlington Heights, IL), 14 Clabeled isobutyrate (American Radiolabeled Chemicals, St. Louis, MO), and 36 Cl (New England Nuclear, Boston, MA) uptake was performed by rapid filtration techniques, as previously presented (27) . In brief, in studies to delineate butyrate/HCO3 exchange, AMV were preloaded with either 50 mM HEPES-Tris (pH 7.5) containing 150 mM KHCO3 or 50 mM HEPES-Tris (pH 7.5) containing 150 mM K-gluconate. Uptake was measured by incubating the AMV for 3 s in medium containing 50 mM MES-Tris (pH 6.0), 25 Butyrate/butyrate exchange. Butyrate/butyrate exchange was determined in AMV preloaded with 50 mM HEPES-Tris (pH 7.5) containing 150 mM Na-butyrate. Uptake was measured by incubating the AMV for 2 s in medium containing 50 mM MES-Tris (pH 6.0), 25 M 14 C-butyrate, and 150 mM of either Na-gluconate or Na-butyrate. Outward butyrate concentration ([butyrate]) and gradient-driven butyrate uptake (i.e., butyrate/butyrate exchange) was calculated by subtracting the uptake in incubation medium with butyrate from that in incubation with gluconate.
Cl/butyrate exchange. Cl/butyrate exchange was determined in AMV preloaded with 50 mM MES-Tris (pH 6.5) containing (in mM) 50 Na-gluconate, 100 K-gluconate, and 10 NMG-gluconate. Uptake was measured by incubating the AMV for 9 s in medium containing (in mM) 50 MES-Tris (pH 5.5), 50 Na-gluconate, 100 K-gluconate, and 10 NMG- 36 Cl. Uptake was also performed in the presence of 1 mM DIDS. Outward [butyrate] gradient-driven Cl uptake (i.e., Cl/ butyrate exchange) was calculated by subtracting the uptake in medium with DIDS from that in the absence of DIDS.
Cl/HCO 3 exchange. Cl/HCO3 exchange was determined in AMV preloaded with 50 mM HEPES-Tris (pH 7.5) containing (in mM) 150 KHCO 3, 20 Na-gluconate, and 10 NMG-gluconate. Uptake was measured for 12 s by incubating the AMV in medium containing (in mM) 50 HEPES-Tris (pH 7.5), 20 Na-gluconate, 10 NMG- 36 Cl, and 150 of either HCO3 or K-gluconate. Uptake in the presence of extravesicular 20 mM Na-butyrate was also measured by replacing Na-gluconate. Outward [HCO 3] gradient-driven Cl uptake (i.e., Cl/HCO3 exchange) Values are given in millimolar per liter of the constituent. pH of all Cl-containing solutions was adjusted to 7.4 with HCl, whereas that of Cl-free solutions was adjusted with H2SO4. HCO3-containing solutions were gassed with 95% O2-5% CO2; HCO3-free solutions were gassed with 100% O2. Both lumen and serosal solutions also contained (in mM) 10 glucose, 5.2 K, 1.2 Ca, and 1.2 Mg. In solution containing isobutyrate, sodium content was 115 mM because the remaining portion was replaced with N-methyl-D-glucamine (NMDG). All lumen solutions were HCO3-free and contained 0.1 mM HEPES II (pH 7.4).
was calculated by subtracting the uptake in medium with HCO3 from that in medium with gluconate.
Cl/Cl exchange. Cl/Cl exchange was determined in AMV preloaded with 50 mM HEPES-Tris (pH 7.5) containing (in mM) 150 KCl, 20 Na-gluconate, and 10 NMG-gluconate. Uptake was measured for 12 s by incubating the AMV in medium containing (in mM) 50 HEPES-Tris (pH 7.5), 20 Na-gluconate, 10 NMG- 36 Cl, and 150 of either KCl or K-gluconate. Uptake in the presence of extravesicular 20 mM Na-butyrate was also measured by replacing Na-gluconate. Outward Cl concentration ([Cl]) gradient-driven Cl uptake (i.e., Cl/Cl exchange) was calculated by subtracting the uptake in medium with K-gluconate from that in medium with KCl.
Cl/OH exchange. Cl/OH exchange was determined in AMV preloaded with 50 mM HEPES-Tris (pH 7.5) containing (in mM) 150 K-gluconate, 20 Na-gluconate, and 10 NMG-gluconate. Uptake was measured for 12 s by incubating the AMV in medium containing (in mM) 150 K-gluconate, 20 Na-gluconate, 10 NMG- 36 Cl and 50 of either HEPES-Tris (pH 7.5) or MES-Tris (pH 5.5). Uptake in the presence of extravesicular 20 mM Na-butyrate was also measured by replacing Na-gluconate. Outward OH concentration ([OH]) gradientdriven Cl uptake (i.e., Cl/OH exchange) was calculated by subtracting the uptake in medium with HEPES-Tris (pH 7.5) from that in medium with MES-Tris (pH 5.5).
Cl channel activity. Cl channel activity was determined in AMV isolated from crypt cells preloaded with 50 mM HEPES-Tris (pH 7.5) containing 160 mM NMG-gluconate and 20 mM Na-gluconate. Intravesicular positive membrane potential-driven uptake was measured for 9 s by incubating the AMV in medium containing (in mM) 50 HEPES-Tris (pH 7.5), 150 of K-gluconate, 10 NMG- 36 Cl, and 20 of either Na-gluconate or Na-butyrate, plus 25 M valinomycin,. Uptake was also performed in the presence of 100 M NPPB. Electrogenic anion channel activity (i.e., Cl channel activity) was calculated by subtracting the uptake in medium with NPPB from that in the absence of NPPB. 
Statistics
Results are presented as means Ϯ SE. Statistical analyses were performed by using paired and unpaired t-test and Bonferroni's one-way ANOVA post hoc test. P Ͻ 0.05 was considered significant.
RESULTS

pH Stat Studies
Effect of butyrate on HCO 3 secretion. Our prior experiments of SCFA-dependent HCO 3 secretion were performed with isobutyrate, a relatively poorly metabolized SCFA (42) . The present studies sought to characterize the effect of lumen butyrate on HCO 3 secretion because butyrate is normally present in large amounts in stool and is both transported and metabolized by the large intestine. Table 2 presents the results of butyrate-dependent HCO 3 secretion indicating that the characteristics of butyrate-dependent HCO 3 secretion are identical to those initially reported for lumen isobutyrate (42) . That is, butyrate-dependent HCO 3 secretion was not altered by the removal of lumen Cl or by the addition of either lumen DIDS (100 M) or lumen NPPB (100 M). Our prior studies with lumen isobutyrate demonstrated that both Cl-dependent HCO 3 secretion and cAMP-induced HCO 3 secretion were downregulated by 25 mM isobutyrate (42) . The 25 mM lumen butyrate also inhibited both Cl-dependent and cAMP-induced HCO 3 secretion (data not shown). Neither 25 mM butyrate nor 25 mM isobutyrate added to the serosal solution resulted in any change in the low rate of basal HCO 3 secretion (data not shown). These observations suggest that SCFA-dependent HCO 3 secretion is closely linked to SCFA transport across the luminal membrane.
Effect of bath HCO 3 and acetazolamide on butyrate-dependent and isobutyrate-dependent HCO 3 secretion. Although butyrate-dependent and isobutyrate-dependent HCO 3 secretion were qualitatively identical, the rate of 25 mM butyratedependent HCO 3 secretion was significantly greater (47%) than that of 25 mM isobutyrate-dependent HCO 3 secretion (8.2 Ϯ 0.03 vs. 5.7 Ϯ 0.05 eq⅐h Ϫ1 ⅐cm Ϫ2 ) ( Table 3) . Isobutyrate-dependent HCO 3 secretion was completely inhibited by the removal of serosal HCO 3 , indicating that an extracellular source of HCO 3 was required for isobutyrate-dependent HCO 3 secretion. This experiment also excluded the possibility that the luminal alkalinization observed in these experiments represented proton absorption via either H ϩ -SCFA Ϫ cotransport or nonionic diffusion of SCFA. In contrast, the removal of serosal HCO 3 resulted in only a 77% inhibition of butyratedependent HCO 3 secretion; the component of butyrate-dependent HCO 3 secretion that was serosal HCO 3 -independent was 1.9 Ϯ 0.01 eq⅐h Ϫ1 ⅐cm Ϫ2 , indicating that the source of HCO 3 secreted in the presence of lumen butyrate was primarily but not solely derived from serosal HCO 3 . Because an intracellular source of HCO 3 was likely linked to the intracellular production of HCO 3 by carbonic anhydrase, experiments were performed with acetazolamide, a carbonic anhydrase inhibitor. Values are means Ϯ SE of HCO3 secretion and were determined by the pH stat technique, as described in MATERIALS AND METHODS. Numbers in parentheses represent number of tissues studied. Serosal solution containing 25 mM HCO3 was gassed with 95% O2-5% CO2. Addition of lumen Cl did not significantly alter HCO3 secretion in the presence of butyrate. All other groups showed significant difference between groups (P Ͻ 0.001). NPPB, 5-nitro-2-(3-phenylpropyl-amino)benzoic acid.
observations with acetazolamide indicate that Ͼ57% of butyrate-dependent HCO 3 secretion is linked to a carbonic anhydrase-mediated process, whereas only 24% of isobutyratedependent HCO 3 secretion was acetazolamide-sensitive. These results suggest that butyrate-dependent HCO 3 secretion is likely the result of both butyrate transport and metabolism. In contrast, isobutyrate-dependent HCO 3 secretion is primarily linked to isobutyrate transport.
To determine whether the effect of serosal HCO 3 and acetazolamide on butyrate-dependent HCO 3 secretion was dependent on the concentration of butyrate used in these experiments, a parallel series of studies were performed with 1 mM lumen butyrate. The effect of both acetazolamide and removal of serosal HCO 3 on HCO 3 secretion observed in the presence of 1 mM butyrate ( (42) . A series of studies were designed to determine the concentration dependence of this inhibition. Cl-dependent HCO 3 secretion in the absence of isobutyrate is completely DIDS-sensitive. Addition of increasing concentrations of isobutyrate up to 25 mM in the presence of 119.8 mM Cl did not alter the rate of total HCO 3 secretion (Fig. 1) . In contrast, a striking qualitative difference was seen when the total HCO 3 secretion was analyzed as the DIDS-sensitive and DIDS-insensitive components. Although 1 mM isobutyrate did not affect DIDS-sensitive Values are means Ϯ SE of HCO3 secretion determined by the pH stat technique, as described in MATERIALS AND METHODS. Numbers in parentheses are number of tissues studied. Serosal solutions with 25 mM HCO3 were gassed with 95% O2-5% CO2, whereas those without HCO3 were gassed with 100% O2. *Comparison between isobutyrate-dependent and butyrate-dependent HCO3 secretion. **Comparison between presence and absence of acetazolamide on HCO3 secretion. NS, not significant. Values are means Ϯ SE of HCO3 secretion determined by the pH stat technique, as described in MATERIALS AND METHODS. Numbers in parentheses represent number of tissues studied. Solutions with 25 mM HCO3 were gassed with 95% O2-5% CO2 whereas those without HCO3 were gassed with 100% O2. *Comparison between isobutyrate-dependent and butyrate-dependent HCO3 secretion. **Comparison between presence and absence of acetazolamide on HCO3 secretion. Fig. 1 . Effect of increasing lumen isobutyrate concentrations on Cl-dependent HCO3 secretion. The rate of total HCO3 secretion was measured in the presence of varying isobutyrate concentrations (0 to 25 mM) at a constant lumen Cl (119.8 mM) concentration (OE). The rate of HCO3 secretion measured in the presence of 100 M DIDS represents DIDS-insensitive HCO3 secretion (F). The rate of DIDS-sensitive HCO3 secretion (E) was derived by subtracting DIDS-insensitive HCO3 secretion from that of total HCO3 secretion. Each point represents the mean from four different tissues. HCO 3 secretion in the presence of lumen Cl, increasing the concentration of isobutyrate (while maintaining Cl concentration constant) revealed an increasing rate of the DIDS-insensitive component of HCO 3 secretion. The DIDS-sensitive component of HCO 3 secretion progressively decreased as the isobutyrate concentration was increased. Thus at 3 mM isobutyrate, HCO 3 secretion was ϳ20% DIDS-insensitive, whereas at 4 mM isobutyrate, 75% of HCO 3 secretion was DIDSinsensitive. HCO 3 secretion was completely DIDS-insensitive at 6 mM isobutyrate. These results indicate that 6 mM isobutyrate had both inhibited Cl-dependent DIDS-sensitive HCO 3 secretion and induced isobutyrate-dependent DIDS-insensitive HCO 3 secretion.
A second set of experiments was performed in the presence of both 1 mM Cl and 3 mM isobutyrate, the concentrations of their respective half-maximal concentrations (Kms) for their stimulation of HCO 3 secretion (42). We found that 1 mM Cl alone and 3 mM isobutyrate alone resulted in HCO 3 secretion that was approximately equal (2.8 Ϯ 0.07 vs. 3.0 Ϯ 0.04 eq⅐h Ϫ1 ⅐cm Ϫ2 ). In the presence of both 1 mM Cl and 3 mM isobutyrate, HCO 3 secretion was identical (2.9 Ϯ 0.09 eq⅐h Ϫ1 ⅐cm Ϫ2 ) to that observed when each was present alone. Addition of DIDS inhibited HCO 3 secretion to 2.4 Ϯ 0.09 eq⅐ h Ϫ1 ⅐cm Ϫ2 , indicating that in the presence of both lumen Cl and isobutyrate, at their respective Kms, HCO 3 secretion was predominantly DIDS-insensitive (83% of total HCO 3 secretion) and thus represented SCFA-dependent and not Cldependent HCO 3 secretion.
Effect of lumen isobutyrate on cAMP-induced HCO 3 secretion. Because 25 mM isobutyrate also inhibited cAMP-induced HCO 3 secretion, parallel experiments were performed to establish the relative isobutyrate concentrations that inhibited cAMP-induced HCO 3 secretion. Addition of increasing concentrations of isobutyrate in the presence of cAMP did not significantly affect the total HCO 3 secretion but altered the relative NPPB-sensitive and NPPB-insensitive component of HCO 3 secretion (Fig. 2) . Inhibiting HCO 3 secretion with NPPB revealed that NPPB-sensitive component decreased, whereas the NPPB-insensitive component increased as lumen isobutyrate concentration was increased. In the absence of isobutyrate, cAMP-induced HCO 3 secretion is 100% NPPB-sensitive. The addition of 1 mM isobutyrate reduced NPPB-sensitive cAMP-induced HCO 3 secretion by 25% (Fig. 2) , whereas 2 mM isobutyrate decreased NPPB-sensitive cAMP-induced HCO 3 secretion by 40%. Increasing isobutyrate to 12.5 mM produced only a modest further increase in inhibition of NPPBsensitive cAMP-induced HCO 3 secretion. In contrast, 15 mM isobutyrate reduced NPPB-sensitive cAMP-induced HCO 3 secretion by 80%, whereas 20 mM isobutyrate completely inhibited NPPB-sensitive cAMP-induced HCO 3 secretion.
Effect of serosal butyrate on Cl-dependent and cAMPinduced HCO 3 secretion. To evaluate whether the inhibition of Cl-dependent and cAMP-induced HCO 3 secretion by butyrate was a function of apical membrane butyrate transport or its intracellular presence and/or metabolism, experiments were performed in which 25 mM butyrate were added to the serosal solution. Fig. 3 demonstrates that the addition of serosal butyrate resulted in a partial (or 35%) inhibition of Cl-dependent HCO 3 secretion (3.6 Ϯ 0.1 eq⅐h Ϫ1 ⅐cm Ϫ2 ) and a 90% inhibition of cAMP-induced HCO 3 secretion (0.5 Ϯ 0.04 eq⅐h Ϫ1 ⅐cm Ϫ2 ).
To further establish whether inhibition of cAMP-stimulated HCO 3 secretion was consequent to intracellular butyrate or due to its metabolic products, experiments were performed by using both the relatively poorly metabolized SCFA isoform, isobutyrate, and 2-bromo-octonoate, an inhibitor of butyrate oxidation to ␣-hydroxy-butyrate. Serosal isobutyrate also inhibited cAMP-stimulated HCO 3 secretion to a similar extent as that of serosal butyrate. Similarly, 300 M 2-bromo-octonoate added to both lumen and serosal solution did not alter the inhibition of cAMP-induced HCO 3 secretion produced by bath 25 mM bath butyrate (0.6 Ϯ 0.06 vs. 0.5 Ϯ 0.04 eq⅐h Ϫ1 ⅐cm Ϫ2 ), indicating that the SCFA inhibition of cAMPinduced HCO 3 secretion is not secondary to a process linked to SCFA metabolism. In contrast, because Cl-dependent HCO 3 secretion was only partially inhibited by 25 mM bath butyrate (compared to its complete inhibition by 25 mM lumen butyrate), butyrate inhibition of Cl-dependent HCO 3 secretion is likely a result of the interaction of butyrate with apical membrane Cl/HCO 3 exchange at a luminal site.
Microperfusion Studies
These pH stat studies demonstrated the presence of butyratedependent HCO 3 secretion. pH stat studies will presumably identify HCO 3 secretion that originated in surface and/or crypt cells but cannot distinguish between these two cell populations. Therefore, to establish the specific site of butyrate-dependent HCO 3 secretion, microperfusion experiments were performed with isolated colonic crypts. As previously reported (13), net HCO 3 absorption was present in the control period in the presence or absence of lumen Cl. Addition of either 10 or 20 mM butyrate to the lumen perfusion solution did not change the rate of net HCO 3 absorption (Fig. 4A) . At no time was net Fig. 2 . Effect of increasing lumen isobutyrate concentrations on cAMPstimulated HCO3 secretion. The rate of total HCO3 secretion was measured in the presence of 8-bromoadenosine 3Ј,5Ј-cyclic monophosphate (8-Br-cAMP) and varying isobutyrate (0 to 25 mM) concentrations (OE). The rate of HCO3 secretion measured in the presence of 100 M 5-nitro-3-(3-phenylpropylamino)benzoic acid (NPPB) represents NPPB-insensitive HCO3 secretion (F). The rate of NPPB-sensitive HCO3 secretion (E) was derived by subtracting NPPB-insensitive HCO3 secretion from that of total HCO3 secretion. Each point represents mean from 4 different tissues.
HCO 3 secretion observed. The effect of butyrate on net fluid movement was also examined. As previously demonstrated (37), net fluid absorption was present in the basal period and remained unaltered after perfusion with lumen 10 or 20 mM butyrate (data not shown). These observations establish that neither butyrate-dependent HCO 3 secretion nor butyrate stimulation of fluid absorption are present in crypt cells, and, as a result, these observations indicate that the butyrate-dependent HCO 3 secretion observed in the pH stat experiments must arise from surface and not from crypt cells.
Prior pH stat studies (42) and those presented in Fig. 2 demonstrated that lumen isobutyrate and lumen butyrate both stimulated HCO 3 secretion and inhibited cAMP-induced HCO 3 secretion. Because butyrate-dependent HCO 3 secretion was not present in the crypt, experiments were designed to determine whether butyrate would inhibit cAMP-induced HCO 3 secretion in the absence of butyrate-dependent HCO 3 secretion. Therefore, HCO 3 secretion was induced in the crypt by the addition of 1 mM 8-Br-cAMP to the serosal solution followed by luminal perfusion of 20 mM butyrate. Figure 4B demonstrates that cAMP-induced HCO 3 secretion remained constant during microperfusion with lumen butyrate. In parallel crypt microperfusion studies the effect of butyrate in the serosal solution on cAMP-induced HCO 3 secretion was also examined. Addition of 20 mM butyrate in the serosal solution also did not affect cAMP-induced HCO 3 secretion. These studies establish that neither lumen nor serosal butyrate downregulated cAMPinduced HCO 3 secretion in isolated colonic crypts.
Apical Membrane Vesicle Studies
Prior studies (23) established the presence of butyrate/HCO 3 exchange in AMV prepared from the distal colon of rats. To determine the cell-specific localization of butyrate/HCO 3 exchange, the effect of an outward-directed [HCO 3 ] gradient on 14 C-butyrate uptake by AMV prepared from isolated surface epithelial and crypt epithelial cells was examined. In these studies, the initial rate of outward [HCO 3 ] gradient-driven 14 C-butyrate uptake (Fig. 5, left) 14 C-butyrate uptake was present in AMV isolated from surface cells (Fig. 5) . In contrast, neither [HCO 3 ] gradient-nor [butyrate] gradient-driven 14 C-butyrate uptake was present in AMV from crypt cells. Additional studies were also performed to examine the integrity of the butyrate transport in AMV from crypt cells. In these studies outward [butyrate] gradient-driven 36 Cl uptake was used as evidence for Cl/butyrate exchange. As shown in Fig. 6 , [butyrate] gradient-driven 36 Cl uptake was present in AMV from both surface and crypt cells, indicating that changes in membrane integrity as a result of membrane preparation were not responsible for the failure to observe either butyrate-HCO 3 or butyrate-butyrate transport function in these AMV prepared from crypt cells. These observations indicate that butyrate/ HCO 3 exchange is selectively present in apical membranes of surface epithelial cells, but is not expressed in apical membranes of crypt epithelial cells consistent with the absence of butyrate-dependent HCO 3 secretion in the microperfusion studies (Fig. 4A) . To determine the relative rates of apical membrane uptake of butyrate and isobutyrate, an experiment was performed to compare the initial rate of 14 ). These observations indicate that the initial rate of butyrate/HCO 3 exchange is greater than that of isobutyrate/HCO 3 exchange.
Studies were also designed to establish whether butyrate directly or indirectly inhibits Cl-dependent (i.e., Cl/HCO 3 exchange) and cAMP-induced (i.e., anion channel) HCO 3 secretion. In these studies, the effect of 20 mM butyrate was examined on Cl/anion exchanges (i.e., Cl/HCO 3, Cl/Cl, and Cl/OH exchanges) and electrogenic Cl channels (Figs. 7 and  8 ). As shown in Fig. 7A , extravesicular presence of 20 mM butyrate almost completely (98%) inhibited Cl/HCO 3 exchange. Because these AMV also contain butyrate/HCO 3 exchange, it is possible that extravesicular butyrate could have inhibited Cl/HCO 3 exchange by dissipating the HCO 3 gradients (Fig. 5 and Ref. 26) . Therefore, the effect of butyrate on Cl/Cl exchange was also examined. As shown in Fig. 7B , Cl/Cl exchange was only partially inhibited (68%) by extravesicular butyrate. Because distinct and separate Cl/HCO 3 and Cl/OH exchanges that could function as Cl/Cl exchange are present in these AMV from distal colon, the effect of butyrate on Cl/OH exchange was also examined. As shown in Fig. 7C , Cl/OH exchange was only partially inhibited (40%) by extravesicular butyrate. In contrast, formate did not inhibit either Cl/HCO 3 exchange, Cl/Cl exchange, or Cl/OH exchange (data not shown). In additional studies, the effect of extravesicular butyrate on apical membrane electrogenic anion channels was examined by determining potential-dependent 36 Cl movement in AMV prepared from crypt cells. As shown in Fig. 8 , an intravesicular positive potential generated by inward K gradient and valinomycin stimulated NPPB (a nonspecific anion channel blocker)-sensitive 36 Cl uptake in AMV isolated from crypt cells. The presence of extravesicular butyrate almost completely inhibited (96%) Cl channel activity. These observations suggest that butyrate directly inhibits both apical membrane Cl/HCO 3 exchange and electrogenic anion channels.
DISCUSSION
Short-chain fatty acids have multiple effects on colonic epithelial cell function including both cell differentiation and epithelial ion transport (4, 7, 15, 20, 22, 23, 25, 33) . SCFA enhance electroneutral Na-Cl and fluid absorption, which is the basis for the concept that SCFA represent an adaptive mechanism for the conservation of calories, fluid, and electrolytes. Thus the primary mechanism of antibiotic-associated diarrhea that is not due to Clostridium difficile is a reduction in SCFA production by colonic bacteria with a resulting decrease in SCFA stimulation of fluid absorption. The present model of SCFA stimulation of Na-Cl absorption is based on SCFA uptake across the apical cell membrane as a result of SCFA/ HCO 3 exchange (or via nonionic diffusion) coupled to NHE and Cl/SCFA exchanges (4, 7, 23, 25) .
Additional effects of SCFA on colonic ion transport have been identified. First, butyrate inhibits cAMP-and cGMPstimulated Cl secretion, but not Ca i -mediated Cl secretion (6, 10) . Second, although the mechanism of both HCO 3 -dependent and butyrate-dependent Na absorption require an NHE and cAMP inhibits both NHE and HCO 3 -dependent Na absorption, butyrate-dependent Na absorption is not altered by cAMP (3, 4) . Third, in the presence of increased mucosal cAMP, butyrate-dependent Na absorption is enhanced as a consequence of an increase in V max without any change in K m (19) . Subsequent studies established that HCO 3 -dependent Na absorption requires NHE-3 isoform and not NHE-2 isoform. In contrast, 36 Cl uptake in AMV from surface and crypt cells. Outward [butyrate] gradient-driven Cl uptake (Cl/ butyrate exchange) was measured in AMV from surface and crypt cells, as described in MATERIALS AND METHODS. Cl/butyrate exchange was identified in AMV prepared from both surface and crypt cells.
either NHE-2 or NHE-3 isoform is linked to butyrate-dependent Na absorption, and cAMP inhibits NHE-3 isoform but activates NHE-2 isoform. (18) . Fourth, SCFA not only stimulate HCO 3 secretion but also inhibit both Cl-dependent and cAMP-induced HCO 3 secretion ( Bicarbonate secretion is an essential intestinal function and is often associated with fluid loss in diarrhea. Despite its critical role, HCO 3 secretion has not been studied as extensively as either Cl secretion or Na absorption in either small or large intestine (11, 35, 36) . During the past several years duodenal HCO 3 secretion has been explored by several investigators primarily in relationship with the mechanism of neutralization of gastric acid secretion (8, 16) . These studies, as well as those previously performed in the ileum and colon (12, 24, 35, 36, 38, 40) , suggested that the mechanism of HCO 3 secretion is primarily Cl-dependent and closely linked to an apical membrane Cl/HCO 3 exchange (12, 24, 36) . Because cAMP also induces HCO 3 secretion, there has been evidence that cAMP-induced HCO 3 secretion may occur via an anion channel (possibly CFTR) or via Cl/HCO 3 exchange coupled to an anion channel (8, 16, 17, 35) .
During the past few years this laboratory has studied HCO 3 secretion by two different methodological approaches: 1) microperfusion of isolated crypts with direct determination of HCO 3 (13, 37) and 2) colonic mucosa stripped of muscular layers in Lucite chambers with pH stat quantitation of HCO 3 (42) . The latter studies identify HCO 3 secretion that may have originated in surface and/or crypt cells. The crypt microperfusion studies demonstrated that cAMP induced HCO 3 secretion in crypt epithelial cells (13) ; in contrast, neither Cl-dependent nor butyrate-dependent HCO 3 secretion was identified during crypt microperfusion (Fig. 4A and Ref. 13 ). This spatial distribution of Cl-dependent and butyrate-dependent HCO 3 correlates closely with the distribution of both Cl/HCO 3 exchange and butyrate/HCO 3 exchange in AMV of surface epithelial cells but not in those of crypt epithelial cells (Fig. 5 and Ref. 26) . In contrast, Cl/butyrate exchange that is most likely not associated with either Cl-dependent or SCFA-dependent HCO 3 secretion is present in apical membranes of both surface and crypt cells (Fig. 6 ). These present studies also provide evidence that Cl-dependent HCO 3 secretion is a result of apical membrane Cl/HCO 3 exchange and not Cl/OH exchange. First, Cl/OH exchange is present in apical membranes of both surface and crypt cells (26) , and 25 mM butyrate almost completely inhibits both Cl/HCO 3 exchange in AMV (Fig. 7A) and Cl-dependent HCO 3 secretion (Fig. 1) , but only results in a 40% downregulation of Cl/OH exchange (Fig. 7C) .
Identification of both Cl-dependent and butyrate-dependent HCO 3 secretion in the pH stat studies (Ref. 42 and Table 2 ) but not in the crypt microperfusion experiments (13 and Fig. 4A ) provide compelling evidence that these two HCO 3 secretory mechanisms are present in surface, but not in crypt epithelial cells. In contrast, both the crypt microperfusion studies and pH stat experiments identified cAMP-induced HCO 3 secretion, but it is not definitely known whether cAMP-induced HCO 3 secretion is present in both surface and crypt epithelial cells or only in crypt epithelial cells. Analyses of the present results provide strong evidence that the HCO 3 secretion identified in Fig. 7 . Effect of butyrate on anion exchanges. Cl/HCO3 exchange, Cl/Cl exchange, and Cl/OH exchange in AMV were measured in the presence and absence of 25 mM butyrate, as described in MATERIALS AND METHODS. Extravesicular butyrate almost completely inhibited Cl/HCO3 exchange, whereas Cl/Cl and Cl/OH exchanges were inhibited by 68 and 40%, respectively. Fig. 8 . Effect of butyrate on anion channel activity. Intravesicular membrane positive potential-dependent electrogenic 36 Cl uptake (anion channel activity) in crypt-AMV was measured, as described in MATERIALS AND METHODS. Extravesicular butyrate almost completely inhibited the electrogenic Cl channels.
pH stat studies primarily represents a surface cell and not a crypt cell process. This conclusion is based on combined demonstration that butyrate failed to downregulate cAMPinduced HCO 3 secretion in the microperfusion studies (Fig.  4B) , whereas in the pH stat studies butyrate inhibited cAMPinduced HCO 3 secretion (Fig. 2) . Thus the components of HCO 3 secretion observed in the pH stat experiments (i.e., Cl-dependent, SCFA-dependent and cAMP-induced) represent HCO 3 transport processes located in surface epithelial and not in crypt epithelial cells. The present results also suggest that cAMP-induced HCO 3 secretion is present in both surface and crypt cells but with varying degrees of sensitivity to butyrate because butyrate inhibits cAMP-induced HCO 3 secretion in the pH stat studies (Fig. 2) but not in the microperfusion experiments (Fig. 4B ). These observations permit the speculation that regulation of cAMP-induced HCO 3 secretion by SCFA differs in surface and crypt cells.
Comparison of butyrate-dependent and isobutyrate-dependent HCO 3 secretion experiments suggests that butyrate induces HCO 3 secretion as a result of both SCFA transport and SCFA metabolism. The conclusion that the primary mechanism of SCFA-dependent HCO 3 secretion is a result of SCFA transport via the apical membrane SCFA/HCO 3 exchange is based on several observations. First, HCO 3 secretion was stimulated by lumen isobutyrate (Table 3) , but not by serosal 25 mM isobutyrate (0.5 Ϯ 0.08 eq⅐h Ϫ1 ⅐cm 2 ). Second, isobutyrate is a poorly metabolized SCFA, and isobutyrate-dependent HCO 3 secretion is completely dependent on bath HCO 3 and is only modestly (25%) inhibited by acetazolamide (Table  3) . Third, high concentrations (i.e., 25 mM) of butyrate that are metabolized by colonic epithelial cells induced HCO 3 secretion that has both a serosal HCO 3 -independent component and was substantially reduced both by carbonic anhydrase inhibition (57%) ( Table 3) and by 2-bromo-octonoate, an inhibitor of butyrate metabolism. Indeed, the acetazolamide-insensitive component of isobutyrate-dependent HCO 3 secretion is almost identical to the acetazolamide-insensitive component of butyrate-dependent HCO 3 secretion (4.3 Ϯ 0.05 vs. 3.6 Ϯ 0.04 eq⅐h Ϫ1 ⅐cm 2 ) (Table 3) . Fourth, at 1 mM butyrate and isobutyrate the effects of bath HCO 3 and acetazolamide are essentially identical, indicating that at low SCFA concentrations the stimulation of HCO 3 secretion is primarily linked to SCFA transport. These observations support the conclusion that butyrate-dependent HCO 3 secretion is a consequence largely but not exclusively of butyrate transport represented by the component of HCO 3 secretion that is serosal HCO 3 -dependent but insensitive to acetazolamide. A smaller fraction of HCO 3 secretion is linked to butyrate metabolism, which is the component of HCO 3 secretion that is serosal HCO 3 -insensitive but sensitive to inhibition of carbonic anhydrase inhibition and butyrate metabolism. It is not unlikely that a small fraction of butyrate-dependent HCO 3 secretion is linked to either butyrate transport or metabolism. The relative importance of butyrate transport on HCO 3 secretion is substantially greater at low butyrate concentrations than at higher ones. Finally, because the initial rate of butyrate/HCO 3 exchange was 35% greater than that of isobutyrate/HCO 3 exchange, the higher rate of butyrate-stimulated than isobutyrate-stimulated HCO 3 secretion was a result of both butyrate transport and metabolism. Mechanism(s) by which SCFA inhibit C1-dependent and cAMP-induced HCO 3 secretion were suggested by our present experiments. One possibility is that the intracellular presence of SCFA results in a decrease in intracellular pH and that both Cl-dependent and cAMP-stimulated HCO 3 secretory processes are pH sensitive. An alternate possibility is that the affinity of these two inhibited HCO 3 secretory processes for HCO 3 is less than that of SCFA/HCO 3 exchange. A third possibility is that SCFA directly inhibits the apical membrane transport process responsible for HCO 3 secretion. The experiments presented in Figs. 7 and 8 provide support for this suggestion by demonstrating that butyrate almost completely inhibited both apical membrane Cl/HCO 3 exchange and apical membrane anion channel activity. Furthermore, the effect of SCFA on these two HCO 3 transporters is not nonspecific, because butyrate did not affect NHE activity and formate did not alter Cl/anion exchange in AMV (V. M. Rashendran and H. J. Binder, unpublished observations). The failure of SCFA to inhibit cAMPinduced HCO 3 secretion in colonic crypts (Fig. 4B) is not readily apparent, but may be a result of different mechanisms of SCFA movement across the basolateral membrane or of different cellular SCFA metabolism in surface and crypt cells.
Presence of both SCFA-dependent HCO 3 secretion and apical membrane SCFA/HCO 3 exchange in surface but not crypt cells, and the demonstration that both SCFA-dependent HCO 3 secretion and SCFA/HCO 3 exchange are DIDS-insensitive suggest that SCFA-dependent HCO 3 secretion is related to an apical membrane SCFA/HCO 3 exchange. The molecular identity of this apical membrane transporter is not known. Recent studies (9, 14, 30 -32) with pig and human colon and human colonic cell lines (CaCo2 and AA/C1) indicate that MCT1 is an apical membrane SCFA transport mechanism. Whereas MCT1-mediated SCFA transport has been proposed both as SCFA Ϫ -H ϩ cotransport and as SCFA/HCO 3 exchange (14, 30, 32) , inhibition of SCFA-dependent HCO 3 secretion by removal of serosal HCO 3 (Table 3) is not consistent with SCFA Ϫ -H ϩ cotransport. Moreover, MCT1-mediated SCFA transport is inhibited by 4-hydroxy cinnamate (4CHC), an inhibitor of monocarboxylate transporters (14, 32) . Because HCO 3 gradient-driven 14 C-butyrate uptake by AMV from rat distal colon is not affected by 4CHC (V. M. Rashendran and H. J. Binder, unpublished observations), it is unlikely that MCT1 mediates SCFA-dependent HCO 3 secretion in the rat distal colon.
These studies have explored the effect of SCFA on colonic HCO 3 secretion and have made possible several conclusions. First, SCFA-induced HCO 3 secretion is the result of both SCFA transport across the apical membrane via a SCFA/HCO 3 exchange and intracellular metabolism of SCFA. Second, SCFA-induced HCO 3 secretion represents a surface epithelial cell process because butyrate-dependent HCO 3 secretion was observed in the pH stat studies but not in the crypt microperfusion experiments and butyrate/HCO 3 exchange was identified in apical membranes of surface but not crypt epithelial cells. Third, SCFA downregulates both Cl-dependent and cAMP-induced HCO 3 secretion with the inhibition of Cldependent HCO 3 secretion linked to direct interaction of SCFA with an apical membrane anion exchange (Fig. 7) . In contrast, SCFA inhibition of cAMP-induced HCO 3 secretion appears dependent primarily on its direct downregulation of the apical membrane anion channel (Fig. 8) . We, therefore, conclude that as SCFA are normally present in the large intestine in significant amounts and lumen SCFA inhibit both Cl-dependent and cAMP-induced HCO 3 secretion, SCFA-dependent HCO 3 secretion is likely the predominant mechanism of HCO 3 secretion in the mammalian colon.
